TY - JOUR T1 - Association between obesity and hospitalization in mild COVID-19 young adult outpatients in Brazil: a prospective cohort study JF - medRxiv DO - 10.1101/2021.08.04.21261538 SP - 2021.08.04.21261538 AU - Ivaine Tais Sauthier Sartor AU - Caroline Nespolo de David AU - Gabriela Heiden Telo AU - Gabriela Oliveira Zavaglia AU - Ingrid Rodrigues Fernandes AU - Luciane Beatriz Kern AU - Márcia Polese-Bonatto AU - Thaís Raupp Azevedo AU - Amanda Paz Santos AU - Walquiria Aparecida Ferreira de Almeida AU - Victor Bertollo Gomes Porto AU - Fernanda Hammes Varela AU - Marcelo Comerlato Scotta AU - Regis Goulart Rosa AU - Renato T. Stein AU - COVIDa study group Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/10/15/2021.08.04.21261538.abstract N2 - Background/Objectives The aim of this study was to evaluate the association between obesity and hospitalization in mild COVID-19 adult outpatients in Brazil.Subjects/Methods Adults with signs and symptoms suggestive of acute SARS-CoV-2 infection who sought two hospitals (one public and one private) emergency department (ED) were prospectively enrolled. Patients with confirmed COVID-19 at inclusion were followed by phone calls at day (D) D7, D14 and D28. Multivariable logistic regression models were employed to explore the association between obesity and other potential predictors for hospitalization.Results A total of 1,050 participants were screened, 310 were diagnosed with COVID-19 by RT-PCR. Median age was 37.4 (IQR 29.8-45.0) years, and 186 (60.0%) were female. Duration of symptoms was 3.0 (IQR 2.0-5.0) days, and 10.0 (IQR 8.0-12.0) was the median number of symptoms at inclusion. A total of 98 (31.6%) were obese, and 243 (78.4%) had no previous medical conditions. Twenty three participants (23/310, 7.4%) required hospitalization during the period. After adjusting, obesity (BMI≥30.0 kg/m2) (OR=2.69, 95%CI 1.63-4.83, P<0.001) and older age (OR=1.05, 95%CI 1.01-1.09, P<0.001), were significantly associated with higher risks of hospitalization.Conclusions Obesity, followed by aging, was the main factor associated with hospital admission for COVID-19 in a young population in a low-middle income country. Our findings highlighted the need for actions to promote additional protection for obese population, such as vaccination, and to encourage lifestyle changes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Brazilian Ministry of Health, through the Institutional Development Program of the Brazilian National Health System (PROADI-SUS) in collaboration with Hospital Moinhos de Vento. The Ministry of Health had no role in study design, sample and data collection, data analysis and interpretation, as well as in the decision to publish.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was performed in accordance with the Decree 466/1210 of the National Health Council and Good Clinical Practice Guidelines after approval by the Hospital Moinhos de Vento Institutional Review Board (IRB 4.637.933). All participants included in this study provided written informed consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available in the manuscript. ER -